Form 4: Omada Health Director Receives RSU Grant

Omada Health's Director, Jonathan D. Root, was granted 915 restricted stock units as part of the company's non-employee director compensation program.

Summary

• Jonathan D. Root, a Director of Omada Health, Inc., acquired 915 shares of Common Stock.
• The acquisition occurred on January 5, 2026, and was reported on January 7, 2026.
• These shares represent Restricted Stock Units (RSUs) granted under the Issuer's Non-Employee Director Compensation Program.
• The RSUs were granted in lieu of retainer fees, with each RSU representing the right to receive one share of Common Stock.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-planned transaction.
• Following this transaction, Jonathan D. Root beneficially owns a total of 179,293 shares of Common Stock.

Sentiment

Score: 6

Explanation: The filing reports a routine grant of Restricted Stock Units (RSUs) to a director as part of a compensation program, which is a neutral to slightly positive event as it aligns director interests with shareholders. It does not indicate any significant operational or financial changes.

Positives

• The grant of Restricted Stock Units (RSUs) to a director aligns the director's interests with those of shareholders, promoting long-term value creation.
• The use of RSUs as compensation for non-employee directors is a common and accepted corporate governance practice.

Risks

• The value of the granted Restricted Stock Units (RSUs) is subject to the future performance and market price fluctuations of Omada Health, Inc. common stock.

Future Outlook

The settlement of the Restricted Stock Units (RSUs) is scheduled to occur on a date selected by the Reporting Person or as otherwise provided by the Non-Employee Director Compensation Program.

Industry Context

The grant of equity-based compensation, such as Restricted Stock Units (RSUs), to non-employee directors is a standard practice across many industries, including healthcare technology, to align director incentives with long-term shareholder value creation. This practice is consistent with corporate governance trends aimed at fostering long-term commitment and performance.

Comparison to Industry Standards

• The use of Restricted Stock Units (RSUs) as a component of non-employee director compensation is a widely adopted practice among publicly traded companies, particularly in the technology and healthcare sectors, similar to companies like Teladoc Health (TDOC) or Livongo Health (acquired by TDOC), which often utilize equity grants to attract and retain talent and align interests.
• A $0 transaction price for RSUs is standard, as these are typically grants for services rather than purchases, reflecting compensation for board service rather than an investment at market price.
• The filing of this transaction under a Rule 10b5-1(c) plan indicates a pre-arranged transaction, a common mechanism for insiders to manage their equity holdings in compliance with insider trading regulations, similar to practices seen at companies like Google (GOOGL) or Apple (AAPL) for their executives and directors.

Corporate Governance

Stakeholder Impact

• Shareholders: The grant of RSUs to a director aligns their interests with shareholders, potentially fostering long-term value creation.

Next Steps

• Settlement of the Restricted Stock Units (RSUs) will occur on a date selected by Jonathan D. Root or as specified by the Non-Employee Director Compensation Program.

Key Dates

Recommendation

This Form 4 filing details a routine equity grant to a director as part of their compensation, which is an expected corporate governance event and does not provide new information that would alter the fundamental investment thesis for Omada Health. It reinforces director alignment but does not suggest a change in operational performance or strategic direction warranting a 'buy' or 'sell' recommendation based solely on this filing.

Keywords

Omada Health, OMDA, Form 4, Insider Transaction, Restricted Stock Units, RSU, Director Compensation, Equity Grant, Jonathan D. Root, 10b5-1 Plan